Related Articles
Formulation and characterization of EGCG for the treatment of superficial bladder cancer
Intravesical treatment of chemotherapeutic agents sensitizes bacillus Calmette‑Guerin by the modulation of the tumor immune environment
Enhanced antitumor effect of combination intravesical mitomycin C and bacillus Calmette-Guerin therapy in an orthotopic bladder cancer model
Identification of a methylation hotspot in the death receptor Fas/CD95 in bladder cancer
The benefit of intraperitoneal chemotherapy for the treatment of colorectal carcinomatosis